Covenant Multifamily Offices’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.05M Sell
6,553
-57
-0.9% -$9.72K 0.19% 87
2021
Q2
$1.09M Buy
6,610
+3,569
+117% +$591K 0.2% 85
2021
Q1
$500K Buy
3,041
+458
+18% +$74.1K 0.1% 108
2020
Q4
$407K Buy
2,583
+367
+17% +$54.2K 0.07% 92
2020
Q3
$330K Sell
2,216
-98
-4% -$14.5K 0.06% 91
2020
Q2
$325K Buy
+2,314
New +$337K 0.06% 118
2020
Q1
Sell
-1,406
Closed -$229K 152
2019
Q4
$229K Buy
+1,406
New +$191K 0.04% 161
2019
Q2
Sell
-100
Closed -$14K 208
2019
Q1
$14K Buy
+100
New +$13.4K ﹤0.01% 175

Other funds holding JNJ

Covenant Multifamily Offices's JNJ Position: Q3 2021 in Review

Covenant Multifamily Offices reduced its Johnson & Johnson (JNJ) stake by 0.86% in Q3 2021, selling an estimated $9.72K and leaving 6,553 shares worth $1.05M. The position accounts for 0.19% of the portfolio, ranked #87.

Covenant Multifamily Offices first reported a position in JNJ in Q1 2019 and has held it in 8 quarters since. The position peaked at $1.09M in Q2 2021. 3,313 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • Covenant Multifamily Offices held 6,553 shares of Johnson & Johnson worth $1.05M as of Q3 2021.
  • Covenant Multifamily Offices sold 57 Johnson & Johnson shares in Q3 2021, an estimated $9.72K.
  • Johnson & Johnson made up 0.19% of Covenant Multifamily Offices's portfolio in Q3 2021, its #87 holding.
  • Covenant Multifamily Offices first reported a position in Johnson & Johnson in Q1 2019 and has held it in 8 quarters since.
  • Covenant Multifamily Offices's Johnson & Johnson position peaked at $1.09M in Q2 2021.
  • 3,313 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.